Powered by: Motilal Oswal
2025-03-19 08:57:40 am | Source: ARETE Securities Ltd
Stock Insights : BPCL Ltd, Brigade Enterprises Ltd, Coal India Ltd, Engineers India Ltd, Insolation Energy Ltd, NTPC Ltd - ARETE Securities Ltd
Stock Insights : BPCL Ltd, Brigade Enterprises Ltd, Coal India Ltd, Engineers India Ltd, Insolation Energy Ltd, NTPC Ltd - ARETE Securities Ltd

Market Updates

The markets are expected to open marginally higher today astrends in GIFT NIFTY indicate a positive start for the broader indexafter NIFTY closed 325 points higher at 22,834 on Tuesday.

BPCL:

The company partnered with BluJ Aerospace, ANERT & CIAL for theworld's first hydrogen-powered VTOL aviation ecosystem and KPIT Techfor hydrogen mobility in Kerala.

Brigade Enterprises:

The company partnered with Gruhas to launch a Rs.300 crore Earth Fund,supporting PropTech and sustainability-focused startups in real estate andconstruction.

Coal India:

The company signed a non-binding MoU with NFTDC to collaborate ontechnology development and expertise enhancement in critical minerals.

Engineers India:

The company secured an EPCM services contract worth Rs.252.95 crorefrom Numaligarh Refinery for a 360 KTPA Polypropylene Unit project.

Insolation Energy:

The company secured Rs.372.20 crore orders, including a Rs.340.20 croreLOA from RREC and a Rs.32 crore module supply order from TeerthGopicon.

NTPC:

The company will issue Rs.4,000 crore unsecured NCDs on 20.03.2025 viaprivate placement at 7.26% p.a. for 15 years.

Shyam Metalics:

The company received NCLT Kolkata’s approval for amalgamation of itssubsidiary Shyam Metalics Flat Product with Shyam Sel and Power.

Sun Pharma:

The company’s subsidiary TARO Pharmaceuticals completed the 100%acquisition of Antibe Therapeutics, Canada, for CAD 4.5 million.

Zen Technologies:

The company completed the acquisition of a 45.33% stake in BhairavRobotics, making it an associate company.

Zydus Lifesciences:

The company received final USFDA approval to manufacture ApalutamideTablets, 60 mg, with $1,099.8 million annual sales in the US (IQVIA).

 

Please refer disclaimer at http://www.aretesecurities.com/

SEBI Regn. No.: INM0000127

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here